Literature DB >> 27801752

Survey on Clinical Practice of Primary Prophylaxis in Portal Hypertension in Children.

Odile Jeanniard-Malet1, Mathieu Duché, Alexandre Fabre.   

Abstract

Primary prophylaxis in portal hypertension in children is controversial, because there are few studies documenting its efficacy on the risk of bleeding. Twenty-eight centres out of the 38 we contacted returned a completed questionnaire about their clinical practices. More than 75% of the centres use endoscopy to screen patients diagnosed with portal cavernoma, biliary atresia, cystic fibrosis, and other fibrotic chronic liver diseases with suspected portal hypertension. In cases of grade 2 varices with red marks and grade 3 varices >90% of centres perform sclerotherapy or endoscopic variceal ligation. Noncardioselective beta-blockers were used by approximately 20% of centres. In conclusion, despite the absence of scientific recommendations there is a tacit consensus concerning the need to screen children with clinical signs of portal hypertension, and to provide primary prophylaxis in cases of endoscopic patterns of high-risk varices.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27801752     DOI: 10.1097/MPG.0000000000001453

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

Review 1.  Hepatic Manifestations of Cystic Fibrosis.

Authors:  Sasan Sakiani; David E Kleiner; Theo Heller; Christopher Koh
Journal:  Clin Liver Dis       Date:  2019-02-21       Impact factor: 6.126

Review 2.  Liver disease in patients with cystic fibrosis.

Authors:  Natasha Kamal; Pallavi Surana; Christopher Koh
Journal:  Curr Opin Gastroenterol       Date:  2018-05       Impact factor: 3.287

3.  Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

4.  Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

5.  Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Daniela Gattini; Lorena I Cifuentes; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2020-01-10

6.  Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Juan Cristóbal Gana; Lorena I Cifuentes; Daniela Gattini; Luis A Villarroel Del Pino; Alfredo Peña; Romina Torres-Robles
Journal:  Cochrane Database Syst Rev       Date:  2019-09-24

7.  Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Juan Cristóbal Gana; Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles
Journal:  Cochrane Database Syst Rev       Date:  2020-11-06

8.  Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Daniela Gattini; Lorena I Cifuentes; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2020-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.